Preformulation in Solid Dosage Form Development (HB) at Meripustak

Preformulation in Solid Dosage Form Development (HB) by Adeyeye, Informa Healthcare

Books from same Author: Adeyeye

Books from same Publisher: Informa Healthcare

Related Category: Author List / Publisher List

  • Price: ₹ 5995.00/- [ 23.00% off ]

    Seller Price: ₹ 4616.00

Sold By: Machwan      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available

Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    PublisherInforma Healthcare
    BindingHard Back
    Publish YearJanuary 2008


    Informa Healthcare Preformulation in Solid Dosage Form Development (HB) by Adeyeye

    During the onset of any clinical trial there are many factors and variables to consider. Funding, time restraints, and regulatory agency guidelines are factors that often influence which variables will be studied, leaving other important information out of the study. Preformulation in Solid Dosage Form Development covers every topic of critical importance to the preformulation stages of drug development. Serving as a handbook or stand-alone reference, this text equips those in academia and the pharmaceutical industry with both basic and applied principles for the characterization of drugs, excipients, and products, and deals with the issues relating to predictability, identification, and product development during preformulation stages through Phase I of clinical trials.

    Key Features:-

    • outlines an updated preformulation program for modern drug development issues that includes particle
    • contains rational designs for the structure of formulation studies
    • covers the importance of preformulation design using artificial neural networks and computational pr
    • discusses the typical drug-excipient interactions that could occur during the course of development
    • includes novel methods to determine the physical and chemical stability of new formulations
    • reviews the structure, content, and format of the preformulation report